Internal Medicine, Medical Oncology · Ann Arbor, MI
NPI
1356427314
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1500 E Medical Center Dr
Ann Arbor, MI, 48109
Phone (734) 936-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$21K
332 services
Medicare patients, 2024
117
Average age 69
Drug cost, 2024
$882K
459 prescriptions
Company payments, 2025
$14K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rashmi Chugh was code 99214 (office e&m - established), 99 times for 68 patients. In total Rashmi Chugh billed 332 services in 13 codes, and Medicare paid $21K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-05-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 99 | 68 | $74.39 | $7,365 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 98 | 65 | $13.14 | $1,288 |
| 99215 Office E&M - Established | Facility | 71 | 41 | $109.86 | $7,800 |
| 99213 Office E&M - Established | Facility | 30 | 22 | $51.10 | $1,533 |
| 99205 Office E&M - New | Facility | 14 | 14 | $127.48 | $1,785 |
By year: 2022 $26K for 257 services; 2023 $22K for 244 services; 2024 $21K for 332 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rashmi Chugh prescribed most often to Medicare patients was Imatinib Mesylate, with 105 prescriptions and refills. In total Rashmi Chugh wrote 459 Medicare prescriptions that cost $882K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imatinib Mesylate Generic | 105 | 108 | 19 | $78K |
| Prochlorperazine Maleate Generic | 37 | 37 | 20 | $838 |
| Ondansetron Hcl Generic | 35 | 35 | 20 | $184 |
| Olanzapine Generic | 30 | 40 | Under 11 | $348 |
| Gleevec Imatinib Mesylate | 23 | 23 | Under 11 | $232K |
| Dexamethasone Generic | 17 | 19 | 11 | $175 |
| Pazopanib Hcl Generic | 16 | 16 | Under 11 | $129K |
| Xarelto Rivaroxaban | 15 | 21 | Under 11 | $11K |
| Prednisone Generic | 11 | 11 | Under 11 | $11.37 |
| Omeprazole Generic | 11 | 28 | Under 11 | $342 |
Brand drugs: 77 claims; generic drugs: 382 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rashmi Chugh $14K ($7,869 in general payments such as food, travel and fees and $6,400 for research) from 6 companies. The largest payer was Recordati_rare_diseases_inc. with $7,269.
| Company | Payments | Amount |
|---|---|---|
| Recordati_rare_diseases_inc. | 8 | $7,269 |
| Pfizer Inc. PFE | 2 | $6,400 |
| Deciphera Pharmaceuticals Inc. | 1 | $600 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.